(Q41032417)

25 September 2017

1 reference

title

The 4S study. Implications for prescribing (English)

1 reference

25 September 2017

A J van Boven

1

1 reference

25 September 2017

J Brügemann

2

1 reference

25 September 2017

P A de Graeff

3

1 reference

25 September 2017

J F May

4

1 reference

25 September 2017

H J Crijns

5

1 reference

25 September 2017

publication date

1 April 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

51

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

507-514

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

25 September 2017

cites work

1 reference

12 December 2020

The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels

1 reference

12 December 2020

Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin

1 reference

12 December 2020

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

12 December 2020

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

1 reference

12 December 2020

Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study

1 reference

12 December 2020

Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

12 December 2020

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

1 reference

12 December 2020

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease

1 reference

12 December 2020

The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia

1 reference

12 December 2020

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1 reference

12 December 2020

Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society

1 reference

12 December 2020

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

12 December 2020

Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris

1 reference

12 December 2020

Long-term safety and efficacy profile of simvastatin

1 reference

12 December 2020

Preventing heart attack and death in patients with coronary disease

1 reference

12 December 2020

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

12 December 2020

Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes

1 reference

12 December 2020

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

12 December 2020

Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting.

1 reference

12 December 2020

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

12 December 2020

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

12 December 2020

Statins prevent coronary heart disease

1 reference

12 December 2020

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1 reference

12 December 2020

Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia

1 reference

12 December 2020

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

12 December 2020

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

12 December 2020

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

1 reference

12 December 2020

Cost and health implications of cholesterol lowering

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction

1 reference

12 December 2020

Cost-effectiveness analysis in heart disease, Part II: Preventive therapies

1 reference

12 December 2020

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

1 reference

12 December 2020

A review of clinical trials comparing HMG-CoA reductase inhibitors

1 reference

12 December 2020

Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction

1 reference

12 December 2020

Lower patient's cholesterol now. Trial evidence shows clear benefits from secondary prevention. 1995.

1 reference

12 December 2020

Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

A general cardiovascular risk profile: The Framingham study

1 reference

12 December 2020

Scandinavian simvastatin study (4S)

1 reference

12 December 2020

Cholesterol lowering does have a role in secondary prevention

1 reference

12 December 2020

Cholesterol reduction yields clinical benefit. A new look at old data

1 reference

12 December 2020

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

1 reference

12 December 2020

Low serum cholesterol concentration and short term mortality from injuries in men and women

1 reference

12 December 2020

Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants

1 reference

12 December 2020

10.2165/00003495-199651040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

1015703375

0 references

1 reference